242 related articles for article (PubMed ID: 8940383)
1. Vascular action of circulating and local natriuretic peptide systems is potentiated in obese/hyperglycemic and hypertensive rats.
Yoshimoto T; Naruse M; Naruse K; Arai K; Imaki T; Tanabe A; Seki T; Hirose S; Muraki T; Demura H
Endocrinology; 1996 Dec; 137(12):5552-7. PubMed ID: 8940383
[TBL] [Abstract][Full Text] [Related]
2. Modulation of vascular natriuretic peptide receptor gene expression in hypertensive and obese hyperglycemic rats.
Yoshimoto T; Naruse M; Naruse K; Fujimaki Y; Tanabe A; Muraki T; Itakura M; Hagiwara H; Hirose S; Demura H
Endocrinology; 1995 Jun; 136(6):2427-34. PubMed ID: 7750464
[TBL] [Abstract][Full Text] [Related]
3. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
[TBL] [Abstract][Full Text] [Related]
5. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects.
Dessì-Fulgheri P; Sarzani R; Rappelli A
J Nephrol; 1998; 11(6):296-9. PubMed ID: 10048495
[TBL] [Abstract][Full Text] [Related]
6. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
7. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats.
Yoshimoto T; Naruse M; Naruse K; Shionoya K; Tanaka M; Tanabe A; Hagiwara H; Hirose S; Muraki T; Demura H
Endocrinology; 1996 Mar; 137(3):1102-7. PubMed ID: 8603580
[TBL] [Abstract][Full Text] [Related]
9. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.
Yoshimoto T; Naruse M; Tanabe A; Naruse K; Seki T; Imaki T; Muraki T; Matsuda Y; Demura H
Endocrinology; 1998 Jan; 139(1):81-8. PubMed ID: 9421401
[TBL] [Abstract][Full Text] [Related]
11. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
12. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptide system in the human retina.
Rollín R; Mediero A; Roldán-Pallarés M; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jan; 10():15-22. PubMed ID: 14737067
[TBL] [Abstract][Full Text] [Related]
14. Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling.
Itoh H; Nakao K
Blood Press Suppl; 1994; 5():49-53. PubMed ID: 7534179
[TBL] [Abstract][Full Text] [Related]
15. Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-beta 1 in cultured aortic smooth muscle cells.
Fujio N; Gossard F; Bayard F; Tremblay J
Hypertension; 1994 Jun; 23(6 Pt 2):908-13. PubMed ID: 7911451
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea.
Kim SZ; Kim HS; Lee KS; Lee SJ; Seul KH; Koh GY; Cho KW; Kim SH
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2671-7. PubMed ID: 10937581
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure.
Liu C; Chen Y; Kang Y; Ni Z; Xiu H; Guan J; Liu K
J Pharmacol Exp Ther; 2011 Oct; 339(1):203-9. PubMed ID: 21737535
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
Sano T; Morishita Y; Matsuda Y; Yamada K
J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
[TBL] [Abstract][Full Text] [Related]
19. C-type natriuretic peptide as a possible local modulator of aldosterone secretion in bovine adrenal zona glomerulosa.
Kawai M; Naruse M; Yoshimoto T; Naruse K; Shionoya K; Tanaka M; Morishita Y; Matsuda Y; Demura R; Demura H
Endocrinology; 1996 Jan; 137(1):42-6. PubMed ID: 8536640
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptide receptors on rat thymocytes: inhibition of proliferation by atrial natriuretic peptide.
Vollmar AM; Schmidt KN; Schulz R
Endocrinology; 1996 May; 137(5):1706-13. PubMed ID: 8612505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
